PHARMEP
0830.777.581 · rovalta.com · 24/09/2026
ACTIVE
PHARMEP
Financial year 2025 · Closed on 31/12/2025
Net result
44,7 k €
+6,9 %over 1 yearGross margin
80,7 k €
+2,7 %over 1 yearEquity
687,3 k €
+7,0 %over 1 yearOverview
Identity
Source · BCE/KBOPHARMEP is a Private limited company incorporated in 2010. Its main activity is: Management consultancy activities. Its registered office is in Mons.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0830.777.581
- Incorporation
- 20/10/2010
- Legal form
- Private limited company
- Registered office
- Chaussée du Roeulx(M) 1188
7021 Mons · WallonieSee on map - Contributed capital
- 20 000,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 80,7 k € | +2.7% | 78,6 k € | -3.0% | 81 k € | +14.9% | 70,5 k € | -9.3% | 77,7 k € |
| EBITDA | 79,1 k € | +2.9% | 76,8 k € | -2.2% | 78,6 k € | +14.1% | 68,9 k € | -10.4% | 76,9 k € |
| Operating result | 75,6 k € | +3.1% | 73,4 k € | -2.3% | 75,1 k € | +16.4% | 64,5 k € | -11.5% | 73 k € |
| Net result | 44,7 k € | +6.9% | 41,8 k € | -39.8% | 69,4 k € | +6.8% | 65 k € | -11.2% | 73,2 k € |
| Balance sheet | |||||||||
| Equity | 687,3 k € | +7.0% | 642,6 k € | +7.0% | 600,8 k € | +13.1% | 531,4 k € | +13.9% | 466,4 k € |
| Total assets | 1,4 M € | +0.2% | 1,4 M € | -0.1% | 1,4 M € | -1.0% | 1,4 M € | +0.5% | 1,4 M € |
| Cash | 14,9 k € | +70.6% | 8,7 k € | +15.0% | 7,6 k € | -58.9% | 18,5 k € | -26.2% | 25 k € |
| Debts | 732,7 k € | -5.4% | 774,7 k € | -5.4% | 819 k € | -9.2% | 902,5 k € | -6.1% | 961,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
PAUL MEURANT
ActiveEnded mandates
Paul Meurant
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2026 | 10/07/2025 | 16/07/2024 | 12/06/2023 | 08/07/2022 | 01/07/2021 |
| General meeting | 27/06/2026 | 09/06/2025 | 10/06/2024 | 12/06/2023 | 13/06/2022 | 14/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 27/06/2026 | 29/06/2026 | French | |
| Abridged model | 31/12/2024 | 09/06/2025 | 10/07/2025 | French | |
| Abridged model | 31/12/2023 | 10/06/2024 | 16/07/2024 | French | |
| Abridged model | 31/12/2022 | 12/06/2023 | 12/06/2023 | French | |
| Abridged model | 31/12/2021 | 13/06/2022 | 08/07/2022 | French | |
| Abridged model | 31/12/2020 | 14/06/2021 | 01/07/2021 | French | |
| Abridged model | 31/12/2019 | 08/06/2020 | 29/07/2020 | French | |
| Abridged model | 31/12/2018 | 10/06/2019 | 16/07/2019 | French | |
| Abridged model | 31/12/2017 | 11/06/2018 | 17/08/2018 | French | |
| Abridged model | 31/12/2016 | 12/06/2017 | 26/07/2017 | French | |
| Abridged model | 31/12/2015 | 09/06/2016 | 12/07/2016 | French | |
| Abridged model | 31/12/2014 | 10/06/2015 | 10/08/2015 | French | |
| Abridged model | 31/12/2013 | 09/06/2014 | 31/07/2014 | French | |
| Abridged model | 31/12/2012 | 10/06/2013 | 29/07/2013 | French | |
| Abridged model | 31/12/2011 | 11/06/2012 | 14/08/2012 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
PAUL MEURANT
ActiveEnded mandates
Paul Meurant
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202544,7 k €↑
- 2024Annual accounts 202441,8 k €↓
- 2023Annual accounts 202369,4 k €↑
- 2022Annual accounts 202265 k €↓
- 2021Annual accounts 202173,2 k €↑
- 2020Annual accounts 202039,2 k €↓
- 2019Annual accounts 201943,6 k €↑
- 2018Annual accounts 201842,8 k €↑
- 2017Annual accounts 201734,1 k €↓
- 2016Annual accounts 201635,8 k €↓
- 2015Annual accounts 201536 k €↑
- 2014Annual accounts 201429,2 k €↓
- 2013Annual accounts 201330,6 k €↓
- 2012Annual accounts 201253,6 k €↑
- 2011Annual accounts 201128,2 k €
- 20/10/2010IncorporationPrivate limited company